Li Xiaomei, Wang Haiyan
Department of Medicine, Renal Division, First Hospital and Institute of Nephrology, Peking University, Beijing, P.R. China.
Adv Chronic Kidney Dis. 2005 Jul;12(3):276-81. doi: 10.1016/j.ackd.2005.03.007.
Chronic kidney disease (CKD) is a worldwide public health issue with poor outcomes and high cost. There is growing evidence that some of the adverse outcomes of CKD can be prevented or delayed by early treatment using angiotensin II-converting enzyme inhibitors and angiotensin II-receptor blockers. A great amount of the world's population has been using traditional Chinese herbal medicine (TCHM) for treatment of CKD and has accumulated their experience for years. In this article, the knowledge and the therapeutic principles of traditional Chinese medicine in the treatment of CKD are briefly reviewed. The efficacy of several TCHMs, supported by either clinical evidence or experimental studies, is presented. The future direction for the study of Chinese herbal medicines in CKD is discussed.
慢性肾脏病（CKD）是一个全球性的公共卫生问题，预后不佳且成本高昂。越来越多的证据表明，使用血管紧张素II转换酶抑制剂和血管紧张素II受体阻滞剂进行早期治疗可以预防或延缓CKD的一些不良后果。世界上大量人口一直在使用传统中药（TCHM）治疗CKD，并积累了多年经验。本文简要回顾了中医治疗CKD的知识和治疗原则。介绍了几种有临床证据或实验研究支持的传统中药的疗效。并讨论了中药在CKD研究中的未来方向。
